PCSK9 and neoplasm: The gain-of-function (GOF) PCSK9 natural variant D374Y [47] enhanced B16 cell-derived tumor growth compared to PCSK9 along with elevations of lipid accumulation; both events were significantly hindered by the loss-of-function (LOF) mutant Q152H [48].